跳至主要内容
临床试验/ITMCTR2100004724
ITMCTR2100004724尚未招募1 期

Correlation of Ovulation Disorder Infertility of Polycystic Ovary Syndrome and Psychological Stress and Study on the Intervention of Bushen Jieyu Tiaochong Formula

Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 40(—)
性别
Female

入选标准

  • (1) They are 20-40 years old and have fertility requirements;
  • (2) Syndrome differentiation of kidney depression and ovulation syndrome of Western medicine accord with PCOS standard of the patients;
  • (3) No ovulation induction drugs including clomiphene citrate were taken within 3 months;
  • (4) After salpingography, the uterus was normal and at least one side of the fallopian tube was unobstructed;
  • (5) Those who can accept follow-up and color Doppler ultrasound examination after treatment;
  • (6) Those who voluntarily receive drug treatment, can return visit on time, and can observe clinical treatment as required;
  • (7) There was no history of serious drug allergy;
  • (8) Willing to cooperate with clinical trials and sign informed consent.

排除标准

  • (1) There are other infertility factors: premature ovarian failure, uterine factors, such as gonadal hypoplasia, reproductive tract malformation, organic diseases of reproductive organs (adenomyosis, hysteromyoma, etc.), pelvic inflammatory diseases; hysterosalpingostomy; the factors of immunity and male side were immune factors and male factors;
  • (2) Other diseases with similar clinical and endocrine signs as PCOS, such as thyroid dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, androgen secreting tumor, Cushing's syndrome, etc;
  • (3) All kinds of malignant tumors, combined with serious cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system diseases and mental illness;
  • (4) Patients with previous history of clomiphene citrate resistance;
  • (5) They have been exposed to teratogenic radiation, poison or drugs and are in the active stage;
  • (6) Patients with incomplete clinical data are difficult to diagnose;
  • (7) Those who fail to comply with the regulations and are not able to follow up regularly;
  • (8) Those who participated in other clinical studies and influenced the results of this study.

研究者

相似试验